Navigation Links
Rainbow research reveals young children with asthma visit emergency department most often
Date:10/27/2013

CLEVELAND: New research from a University Hospitals Rainbow Babies & Children's Hospital (UH Rainbow) study found that children ages 1 to 3 years accounted for one-fifth of all emergency department (ED) visits caused by complications from asthma, representing the highest proportion of visits among asthma patients under age 21. In addition, 55 percent of all ED visits due to asthma occurred in boys, and fall months September, October and November had a relatively high proportion of visits compared to other times of the year. The research was presented at the American Academy of Pediatrics (AAP) National Conference in Orlando.

Asthma is the most common chronic childhood disease, affecting close to seven million children in the U.S. More than two-thirds of asthma-induced ED visits occurred among children residing in areas with annual household income levels below $50,000. The study also found the total asthma-related ED charges across the U.S. totaled $2.6 billion, averaging to about $1,300 per visit. Medicaid paid for half of all these visits, while private insurance plans paid for about 35 percent. The majority of children were treated and discharged routinely from the ED, while about one in 10 were admitted to the hospitals as patients.

"This study looked at more than 2.3 million ED visits among children with asthma, and we identified some interesting trends that give a baseline to find better ways to help children with asthma control this very treatable disease," said Aparna Roy, MD, MPH, lead author of the study and resident at UH Rainbow and Case Western Reserve University School of Medicine. "These findings reinforce the need to educate parents, especially those with children at higher risk, about how to manage the disease on a day-to-day basis to avoid costly emergency visits."

At AAP, Dr. Roy also presented an analysis of adverse drug events (ADE) among hospitalized children in the U.S. from 2003 to 2010. Results revealed that medication errors and ADEs in pediatric inpatient settings gradually increased between 2003 and 2010, although the cause for this increase requires further study. Overall, of the more than 62 million hospitalizations among children in the U.S. during this time frame, less than one percent experienced ADEs.

"While the overall incidence of adverse drug events among hospitalized children was low, nearly half a million children experienced ADEs and the steady upward trend of ADEs among this population is worrisome. We are planning additional research to evaluate whether better ADE reporting may play a role in this increase and if we can identify common causes so we can better reduce the number that occur," said Dr. Roy.


'/>"/>

Contact: Katelyn McCarthy
katelyn.mccarthy@uhhospitals.org
University Hospitals Case Medical Center
Source:Eurekalert

Related medicine news :

1. Voices Against Brain Cancer Applauds Mother For Starting Riah’s Rainbow Organization
2. Historic Lodge at Rainbow Trout Ranch Celebrates Eighty Five Years in Southern Colorado
3. Antibiotics Procurement Research Report Now Available from IBISWorld
4. Tattoo Studios in Australia Industry Market Research Report Now Updated by IBISWorld
5. BCC Research Publishes A New Report On Global Markets For Telemedicine Technologies
6. Coronary Stents Market to Grow at a CAGR of 9.1% to 2015 in New Research Report at RnRMarketResearch.com
7. Slim Weight Patch - Scientifically Researched and Proven Weight Loss System Now Available in the Market with 1 Month Extra Supply
8. I-Tech Project Will Turn Out in Lower Costs for the Clinical Research Arena
9. Chicago-Area Infertility Specialist Richard Sherbahn Presents New Research Showing that High AMH levels are Correlated with Better IVF Outcomes
10. Retirement Communities in the US Industry Market Research Report from IBISWorld Has Been Updated
11. New research on innovative ways to prevent, treat childhood obesity presented at AAP conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Collagen Matrix, Inc., ("Collagen ... and manufacturing of collagen and mineral based medical ... that Bill Messer has joined the ... further leverage the growing portfolio of oral surgery, ... Bill joins the Collagen Matrix executive team ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology: